Most investigations on the antitumor effects of T cells have centered around CD8+ T cells due to their high expression in various malignancies, ease of isolation and in vitro manipulation, and their keen ability to directly lyse tumor cells [87]. This evidence concerns the gene CD8A and neoplasm.